Suppr超能文献

明尼苏达州奥姆斯特德县 1970 年至 2007 年轻度恶性黑色素瘤的发病率。

Incidence of lentigo maligna in Olmsted County, Minnesota, 1970 to 2007.

机构信息

Mayo Medical School, Mayo Clinic College of Medicine, Rochester, Minnesota.

Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota.

出版信息

J Am Acad Dermatol. 2014 Mar;70(3):443-8. doi: 10.1016/j.jaad.2013.11.008. Epub 2013 Dec 24.

Abstract

BACKGROUND

The incidence of lentigo maligna (LM) may be increasing, but no population-based epidemiologic studies have been performed to our knowledge.

OBJECTIVE

We sought to determine the incidence of LM in Olmsted County, Minnesota, along with overall and recurrence-free survival.

METHODS

Using the Rochester Epidemiology Project, we identified all adult residents of Olmsted County, Minnesota, with a first lifetime diagnosis of LM between 1970 and 2007. Medical records were reviewed to determine demographic, clinical, and surgical data, and incidence and survival were calculated.

RESULTS

Among 145 patients identified, median (range) age at diagnosis of LM was 70 (33-97) years. Treatment changed over time, with Mohs micrographic surgery becoming available after 1986. No patients died of LM; 5 had local recurrence. Estimated local recurrence-free survival at 5, 10, 15, and 20 years after diagnosis was 98%, 96%, 92%, and 92%, respectively. Overall age- and sex-adjusted incidence of LM among adults was 6.3 per 100,000 person-years, increasing from 2.2 between 1970 and 1989 to 13.7 between 2004 and 2007.

LIMITATIONS

Retrospective study design and homogeneous population are limitations.

CONCLUSION

The incidence of LM increased significantly among residents of Olmsted County, Minnesota, over an extended time frame, with incidence being significantly higher among men than women and increasing with age.

摘要

背景

据我们所知,恶性雀斑样痣(LM)的发病率可能正在上升,但尚未开展基于人群的流行病学研究。

目的

我们旨在确定明尼苏达州奥姆斯特德县 LM 的发病率,以及总生存率和无复发生存率。

方法

利用罗切斯特流行病学项目,我们确定了在 1970 年至 2007 年间,奥姆斯特德县首次被诊断为 LM 的所有成年居民。查阅病历以确定人口统计学、临床和手术数据,并计算发病率和生存率。

结果

在确定的 145 例患者中,LM 的中位(范围)诊断年龄为 70(33-97)岁。治疗随时间而变化,Mohs 显微外科手术于 1986 年后开始应用。没有患者死于 LM;5 例患者局部复发。诊断后 5、10、15 和 20 年的局部无复发生存率估计分别为 98%、96%、92%和 92%。成年人的整体年龄和性别调整后的 LM 发病率为 6.3/100,000 人年,从 1970 年至 1989 年的 2.2 上升到 2004 年至 2007 年的 13.7。

局限性

回顾性研究设计和同质人群是其局限性。

结论

在明尼苏达州奥姆斯特德县,LM 的发病率在较长时间内显著增加,男性发病率明显高于女性,且随年龄增长而增加。

相似文献

引用本文的文献

3
Lentigo Maligna: Clinical Presentation and Appropriate Management.恶性雀斑样痣:临床表现与合理治疗
Clin Cosmet Investig Dermatol. 2020 Nov 13;13:837-855. doi: 10.2147/CCID.S224738. eCollection 2020.
4
Emerging strategies to treat rare and intractable subtypes of melanoma.治疗罕见和难治性黑色素瘤亚型的新兴策略。
Pigment Cell Melanoma Res. 2021 Jan;34(1):44-58. doi: 10.1111/pcmr.12880. Epub 2020 Apr 24.
8
Interventions for melanoma in situ, including lentigo maligna.原位黑色素瘤的干预措施,包括恶性雀斑样痣。
Cochrane Database Syst Rev. 2014 Dec 19;2014(12):CD010308. doi: 10.1002/14651858.CD010308.pub2.

本文引用的文献

1
Lentigo maligna.恶性雀斑样痣。
Actas Dermosifiliogr. 2013 Nov;104(9):757-75. doi: 10.1016/j.ad.2012.05.006. Epub 2012 Jul 31.
4
Lentigo maligna.恶性雀斑样痣
Dermatol Ther. 2008 Nov-Dec;21(6):439-46. doi: 10.1111/j.1529-8019.2008.00244.x.
7
History of the Rochester Epidemiology Project.罗切斯特流行病学项目的历史。
Mayo Clin Proc. 1996 Mar;71(3):266-74. doi: 10.4065/71.3.266.
9
Lentigo maligna and lentigo maligna melanoma.恶性雀斑样痣和恶性雀斑样痣黑色素瘤。
J Am Acad Dermatol. 1995 Dec;33(6):923-36; quiz 937-40. doi: 10.1016/0190-9622(95)90282-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验